<DOC>
	<DOCNO>NCT00133822</DOCNO>
	<brief_summary>The purpose study determine whether administration risperidone effective treatment selective serotonin reuptake inhibitor ( SSRI ) -resistant post-traumatic stress disorder ( PTSD ) civilian .</brief_summary>
	<brief_title>Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial</brief_title>
	<detailed_description>Individuals PTSD often experience anxiety attack , nightmare , repeat unwanted memory experience witness life-threatening event , serious accident natural disaster , traumatic event physical sexual abuse . Risperidone approve Food Drug Administration treatment psychotic disorder find helpful PTSD depression , still consider investigational purpose study . All qualify participant start sertraline ( Zoloft ) eight week . Patients still symptomatic end phase , invite join second portion study randomly assign receive risperidone placebo ( sugar pill ) addition sertraline . Participants monitor regularly medication effect , adverse event , PTSD symptom .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Meets criteria DSMIV PTSD minimum one month duration ClinicianAdministered PTSD Scale ( CAPS ) score &gt; = 50 Able read complete questionnaire interview Negative urine drug screen Pregnant nursing Primary psychotic disorder ; psychotic disorder ; cognitive disorder . Prominent suicidal homicidal ideation Alcohol substance dependence within 3 month start study Primary anxiety disorder bipolar disorder Patients currently treat antipsychotic medication Patients active psychotherapy aim PTSD Combatrelated PTSD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Post-Traumatic Stress Disorder</keyword>
	<keyword>Sertraline</keyword>
	<keyword>Risperidone</keyword>
</DOC>